BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 8356264)

  • 21. Incidental thyroid Tc-99m methylene diphosphonate (MDP) uptake in a patient affected by polynodular goiter at bone scintigraphy.
    Bertagna F; Bosio G; Giubbini R
    Nucl Med Rev Cent East Eur; 2009; 12(2):81-2. PubMed ID: 20235059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc-99m diphosphonate uptake in malignant fibrous histiocytoma: a possible iron-related effect.
    Spencer RP; Evans DD; Forouhar F; Fetters DV; Yeh SD
    Clin Nucl Med; 1988 Oct; 13(10):734-5. PubMed ID: 2846223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
    MacDonald J
    J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental detection of gastrointestinal stromal tumor by Tc-99m MDP bone scan.
    Shepherd TM; Idakoji IA; Pampaloni MH
    Clin Nucl Med; 2012 Feb; 37(2):198-9. PubMed ID: 22228353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
    Sharma R; Mondal A; Bhatnagar A; Chakravarty KL; Mishra P; Chopra MK; Rawat HS; Kashyap R
    Clin Nucl Med; 1998 Nov; 23(11):758-63. PubMed ID: 9814564
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Mandiwana V; Kalombo L; Grobler A; Zeevaart JR
    Appl Radiat Isot; 2018 Nov; 141():51-56. PubMed ID: 30170270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualization of soft tissue by technetium-99m MDP in polymyositis. Case reports.
    Otsuka N; Fukunaga M; Ono S; Nagai K; Morita K; Tomomitsu T; Yanagimoto S; Morimoto K; Terao A; Morita R
    Clin Nucl Med; 1988 Apr; 13(4):291-3. PubMed ID: 3370897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple extraosseous accumulation of 99mTc-MDP in acute lymphocytic leukemia and reference to literature.
    Xu YH; Song HJ; Qiu ZL; Luo QY
    Hell J Nucl Med; 2010; 13(3):273-6. PubMed ID: 21193884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periarticular bone sites associated with traumatic injury: false-positive findings with In-111-labeled white blood cell and Tc-99m MDP scintigraphy.
    Seabold JE; Ferlic RJ; Marsh JL; Nepola JV
    Radiology; 1993 Mar; 186(3):845-9. PubMed ID: 8430197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
    Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
    Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy.
    Aso Y; Sato A; Tayama K; Takanashi K; Satoh H; Takemura Y
    Intern Med; 1996 May; 35(5):392-5. PubMed ID: 8797054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
    al-Nahhas AM; Jinnouchi S; Anagnostopoulos C; Hirsch W; Heary T; McCready VR
    Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
    Park-Holohan SJ; Blake GM; Fogelman I
    Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental study of vascularized bone: quantitative analysis of bone scintigraphy and histology.
    Takato T; Harii K; Nakatsuka T; Ohtake T
    J Reconstr Microsurg; 1988 Oct; 4(5):391-7. PubMed ID: 3058962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tc-99m MDP uptake in retroperitoneal malignant peripheral nerve sheath tumor and its metastases.
    Li L; Kuang A; Sheng S
    Clin Nucl Med; 2006 Jan; 31(1):44-5. PubMed ID: 16374127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89.
    Manetou A; Limourls GS
    Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.